The finding that administration of anti‐NKG2D does not inhibit HDM‐mediated allergic asthma contrasts with earlier research that used mice genetically deficient for NKG2D (Klrk1−/−) (Farhadi et al, 2014). This evidence concerns the gene KLRK1 and allergic asthma.